Prevention of HIV-1 infection by phthalocyanines

Antiviral Research

Volumn 59, Issue 2, 2003, Pages 99-109

  Vzorov, Andrei N ^a   Marzilli, Luigi G ^b   Compans, Richard W ^a   Dixon, Dabney W ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

HIV; Human immunodeficiency virus; Phthalocyanine; Porphyrazine

Indexed keywords

ALCIAN BLUE; ALEC BLUE; ALUMINUM CARBOXYPHTHALOCYANINE; CD4 ANTIGEN; COBALT CARBOXYPHTHALOCYANINE; GLYCOPROTEIN GP 120; IRON PHTHALOCYANINE; PHTHALOCYANINE ALUMINUM; PHTHALOCYANINE COPPER; PHTHALOCYANINE DERIVATIVE; PHTHALOCYANINE ZINC; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; VIRUS INACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0042706410     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00035-4     Document Type: Article

References (54)

1. Ben-Hur E., Oetjen J., Horowitz B. Silicon phthalocyanine Pc 4 and red light causes apoptosis in HIV-infected cells. Photochem. Photobiol. 65:1997;456-460.
2. Ben-Hur E., Chan W.S., Yim Z., Zuk M.M., Dayal V., Roth N., Heldman E., Lazo A., Valeri C.R., Horowitz B. Photochemical decontamination of red blood cell concentrates with the silicon phthalocyanine PC 4 and red light. Dev. Biol. Stand. 102:2000;149-155.
3. Bentley M.E., Morrow K.M., Fullem A., Chesney M.A., Horton S.D., Rosenberg Z., Mayer K.H. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam. Plann. Perspect. 32:2000;184-188.
4. Blasco R., Moss B. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene. 158:1995;157-162.
5. Chackerian B., Haigwood N.L., Overbaugh J. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology. 213:1995;386-394.
6. Clarke J.G., Peipert J.F., Hillier S.L., Heber W., Boardman L., Moench T.R., Mayer K. Microflora changes with the use of a vaginal microbicide. Sex Transm. Dis. 29:2002;288-293.
7. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
8. Darroch J.E., Frost J.J. Women's interest in vaginal microbicides. Fam. Plann. Perspect. 31:1999;16-23.
9. De Clercq E. New developments in anti-HIV chemotherapy. Biochim. Biophys. Acta. 1587:2002a;258-275.
10. De Clercq E. Strategies in the design of antiviral drugs. Nat. Rev. Drug Discov. 1:2002b;13-25.
11. Delezay O., Koch N., Yahi N., Hammache D., Tourres C., Tamalet C., Fantini J. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS. 11:1997;1311-1318.
12. Dixon, D.W., Schinazi, R.F., Marzilli, L.G., 1992. Method for Inhibiting Infection of Replication of Human Immunodeficiency Virus with Porphyrin and Phthalocyanine Antiviral Compositions. U.S. Patent 5,109,016.
13. Dixon, D.W., Marzilli, L.G., Schinazi, R.F., 1994. Porphyrin and Phthalocyanine Antiviral Compositions. U.S. Patent 5,281,616.
14. D'Souza M.P., Cairns J.S., Plaeger S.F. Current evidence and future directions for targeting HIV entry - therapeutic and prophylactic strategies. JAMA. 284:2000;215-222.
15. Fantini J., Cook D.G., Nathanson N., Spitalnik S.L., Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2700-2704.
16. Fichorova R.N., Tucker L.D., Anderson D.J. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J. Infect. Dis. 184:2001;418-428.
17. Gabelnick H.L., Harper M.J. The promise of public/private sector collaboration in the development of vaginal microbicides. Int. J. Gynaecol. Obstet. 67(Suppl. 2):1999;S31-S38.
18. Gallaher W.R., Ball J.M., Garry R.F., Martin-Amedee A.M., Montelaro R.C. A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses. 11:1995;191-202.
19. Gaspard S., Tempete C., Werner G.H. Studies on photoinactivation by various phthalocyanines of a free or replicating non-enveloped virus. J. Photochem. Photobiol. B. 31:1995;159-162.
20. Hammett T.M., Mason T.H., Joanis C.L., Foster S.E., Harmon P., Robles R.R., Finlinson H.A., Feudo R., Vining-Bethea S., Jeter G., Mayer K.H., Doherty-Iddings P., Seage G.R. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities. Sex Transm. Dis. 27:2000;119-126.
21. Harouse J.M., Bhat S., Spitalnik S.L., Laughlin M., Stefano K., Silberberg D.H., Gonzalez-Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 253:1991;320-323.
22. Harouse J.M., Collman R.G., Gonzalez-Scarano F. Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3′ sulfo-galactosyl ceramide-positive cell line. J. Virol. 69:1995;7383-7390.
23. Harrison P.F. Microbicides: forging scientific and political alliances. AIDS Patient Care STDS. 14:2000;199-205.
24. Horowitz B., Williams B., Rywkin S., Prince A.M., Pascual D., Geacintov N.E., Valinsky J. Inactivation of viruses in blood with aluminum phthalocyanine derivatives. Transfusion. 31:1991;102-108.
25. Horowitz B., Rywkin S., Margolis-Nunno H., Williams B., Geacintov N.E., Prince A.M., Pascual D., Ragno G., Valeri C.R., Huima-Byron T. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AlPc) sulfonates. Blood Cells. 18:1992;141-150.
26. Isaacs C.E., Pullarkat R., Kascsak R. Development of a topical vaginal microbicide: lessons learned from human milk. Adv. Exp. Med. Biol. 501:2001;223-232.
27. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:1992;2232-2239.
28. Lapham C.K., Ouyang J., Chandrasekhar B., Nguyen N.Y., Dimitrov D.S., Golding H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science. 274:1996;602-605.
29. Margolis-Nunno H., Ben-Hur E., Gottlieb P., Robinson R., Oetjen J., Horowitz B. Inactivation by phthalocyanine photosensitization of multiple forms of human immunodeficiency virus in red cell concentrates. Transfusion. 36:1996;743-750.
30. Mascola J.R. Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1. Vaccine. 20:2002;1922-1925.
31. Moor A.C.E., Wagenaars-van Gompel A.E., Hermanns R.C.A., van der Meulen J., Smit J., Wilschut J., Brand A., Dubbelman T.M.A.R., van Steveninck J. Inhibition of various steps in the replication cycle of vesicular stomatitis virus contributes to its photoinactivation by AlPcS4 or Pc4 and red light. Photochem. Photobiol. 69:1999;353-359.
32. Neurath A.R., Strick N., Haberfield P., Jiang S. Rapid prescreening for antiviral agents against HIV-1 based on their inhibitory activity in site-directed immunoassays. II. Porphyrins reacting with the V3 loop of gp120. Antivir. Chem. Chemother. 3:1992;55-63.
33. Neurath A.R., Strick N., Jiang S. Rapid prescreening for antiviral agents against HIV-1 based on their inhibitory activity in site-directed immunoassays. Approaches applicable to epidemic HIV-1 strains. Antivir. Chem. Chemother. 4:1994;207-214.
34. Neurath A.R., Strick N., Debnath A.K. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human-immunodeficiency-virus (HIV-1) envelope glycoprotein gp120. J. Mol. Recognit. 8:1995;345-357.
35. Owens R.J., Compans R.W. Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J. Virol. 63:1989;978-982.
36. Richardson B.A., Lavreys L., Martin H.L. Jr., Stevens C.E., Ngugi E., Mandaliya K., Bwayo J., Ndinya-Achola J., Kreiss J.K. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm. Dis. 28:2001;394-400.
37. Ritter G.D. Jr., Mulligan M.J., Lydy S.L., Compans R.W. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology. 197:1993;255-264.
38. Rywkin S., Ben-Hur E., Malik Z., Prince A.M., Li Y.-S., Kenney M.E., Oleinick N.L., Horowitz B. New phthalocyanines for photodynamic virus inactivation in red blood cell concentrates. Photochem. Photobiol. 60:1994;165-170.
39. Sattentau Q.J., Moore J.P. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:1991;407-415.
40. Smetana Z., Mendelson E., Manor J., van Lier J.E., Ben-Hur E., Salzberg S., Malik Z. Photodynamic inactivation of herpes viruses with phthalocyanine derivatives. J. Photochem. Photobiol. B. 22:1994;37-43.
41. Spieler R. Seaweed compound's anti-HIV efficacy will be tested in southern Africa. Lancet. 359:2002;1675.
42. Stafford M.K., Ward H., Flanagan A., Rosenstein I.J., Taylor-Robinson D., Smith J.R., Weber J., Kitchen V.S. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17:1998;327-331.
43. Tobin G.J., Ennis W.H., Clanton D.J., Gonda M.A. Inhibition of bovine immunodeficiency virus by anti-HIV-1 compounds in a cell culture-based assay. Antivir. Res. 33:1996;21-31.
44. Trujillo J.R., Goletiani N.V., Bosch I., Kendrick C., Rogers R.A., Trujillo E.B., Essex M., Brain J.D. T-tropic sequence of the V3 loop is critical for HIV-1 infection of CXCR4-positive colonic HT-29 epithelial cells. J. Acquir. Immune Defic. Syndr. 25:2000;1-10.
45. Turville S.G., Cameron P.U., Arthos J., MacDonald K., Clark G., Hart D., Cunningham A.L. Bitter-sweet symphony: defining the role of dendritic cell gp120 receptors in HIV infection. J. Clin. Virol. 22:2001;229-239.
46. Upmalis D.H. Collaboration with academia in the development of vaginal microbicides. Int. J. Gynaecol. Obstet. 67(Suppl. 2):1999;S55-S58.
47. van de Wijgert J., Coggins C. Microbicides to prevent heterosexual transmission of HIV: 10 years down the road. BETA. 15:2002;23-28.
48. Vzorov A.N., Compans R.W. Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization. J. Virol. 74:2000;8219-8225.
49. Weber J.H., Busch D.H. Complexes derived from strong field ligands. XIX. Magnetic properties of transition metal derivatives of 4,4′,4″,4″′-tetrasulfophthalocyanine. Inorg. Chem. 4:1965;469-471.
50. Weber J., Nunn A., O'Connor T., Jeffries D., Kitchen V., McCormack S., Stott J., Almond N., Stone A., Darbyshire J. 'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo. AIDS. 15:2001;1563-1568.
51. Yahi N., Baghdiguian S., Moreau H., Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J. Virol. 66:1992;4848-4854.
52. Yahi N., Baghdiguian S., Fantini J. Production of a highly cytopathic HIV-1 isolate from a human mucosal epithelial cell line cultured on microcarrier beads in serum-free medium. In Vitro Cell Dev. Biol. Anim. 31:1995;62-66.
53. Zambruno G., Giannetti A., Bertazzoni U., Girolomoni G. Langerhans cells and HIV infection. Immunol. Today. 16:1995;520-524.
54. Zmudzka B.Z., Strickland A.G., Beer J.Z., Ben-Hur E. Photosensitized decontamination of blood with the silicon phthalocyanine Pc 4: no activation of the human immunodeficiency virus promoter. Photochem. Photobiol. 65:1997;461-464.